Congratulations to Dr. Steffen Schneider from #HelmholtzMunich for being named "Early Career Scientist of the Year" 2024! 🎉👏 🔗 Watch his award video: t1p.de/3bze7 @stes.io @www.helmholtz.de @ellis.eu @zeit.de @comphealthmunich.bsky.social

„academics-Nachwuchswissenschaftler des Jahres 2024“: Dr. Steffen Schneider

Enjoy the videos and music you love, upload original content, and share it all with friends, family, and the world on YouTube.

t1p.de

We‘re excited to welcome @slobentanzer.bsky.social, new PI at the intersection of @diabresearch-dzd.bsky.social and @comphealthmunich.bsky.social @www.helmholtz-munich.de! His group focuses on „Accessible Biomedical AI Research“ - and he‘s hiring! Open positions on slolab.ai and: bit.ly/slolab.

PhD Candidates and Postdocs in Accessible Biomedical AI (f/m/x)

jobs.helmholtz-muenchen.de

At the first CHC Townhall Meeting we awarded the 3 best papers of Q1, 2025. 🎉 Congratulations to Manuel Tran, Theresa Willem and Dominik Klein.

🚀 Exciting Career Opportunity! Helmholtz Munich & Roche are looking for an Early Career Investigator in AI for Nucleic Acid Based Medicines 🧬💡 Join our innovative team and help push the boundaries of medical research. 👉 Learn more and apply: bit.ly/ECI_Munich ❗3 days left

Early Career Investigator (f/m/x) in AI for Nucleic Acid Based Medicines

bit.ly